336 related articles for article (PubMed ID: 31327296)
21. Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with Thrombocytopenia.
Mowla A; Kamal H; Lail NS; Vaughn C; Shirani P; Mehla S; Rajabzadeh-Oghaz H; Deline C; Ching M; Crumlish A; Sawyer RN
J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):1414-1418. PubMed ID: 28438515
[TBL] [Abstract][Full Text] [Related]
22. Timely Reperfusion in Stroke and Myocardial Infarction Is Not Correlated: An Opportunity for Better Coordination of Acute Care.
Sauser Zachrison K; Levine DA; Fonarow GC; Bhatt DL; Cox M; Schulte P; Smith EE; Suter RE; Xian Y; Schwamm LH
Circ Cardiovasc Qual Outcomes; 2017 Mar; 10(3):. PubMed ID: 28283469
[TBL] [Abstract][Full Text] [Related]
23. Safety of Intravenous Thrombolysis in Chronic Intracranial Hemorrhage: A Five-Year Multicenter Study.
Zand R; Tsivgoulis G; Sadighi A; Singh M; McCormack M; Shahjouei S; Goyal N; Noorbakhsh-Sabet N; Alexandrov AW; Alexandrov AV
J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):620-624. PubMed ID: 29100859
[TBL] [Abstract][Full Text] [Related]
24. Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful?
Ringleb PA; Schellinger PD; Schranz C; Hacke W
Stroke; 2002 May; 33(5):1437-41. PubMed ID: 11988629
[TBL] [Abstract][Full Text] [Related]
25. Thrombolytic therapy with recombinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cumulative meta-analysis.
Wardlaw JM; Sandercock PA; Berge E
Stroke; 2003 Jun; 34(6):1437-42. PubMed ID: 12730560
[TBL] [Abstract][Full Text] [Related]
26. The Risk of Hemorrhagic Transformation After Thrombolysis for Acute Ischemic Stroke in Chinese Versus North Americans: A Comparative Study.
Xu X; Wang D; Wang F; Norton C; Liu X; Selim M
J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2381-2387. PubMed ID: 29778315
[TBL] [Abstract][Full Text] [Related]
27. Impact of acute ischemic stroke treatment in patients >80 years of age: the specialized program of translational research in acute stroke (SPOTRIAS) consortium experience.
Willey JZ; Ortega-Gutierrez S; Petersen N; Khatri P; Ford AL; Rost NS; Ali LK; Gonzales NR; Merino JG; Meyer BC; Marshall RS
Stroke; 2012 Sep; 43(9):2369-75. PubMed ID: 22798327
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of Nonagenarians with Acute Ischemic Stroke Treated with Intravenous Thrombolytics.
Behrouz R; Masjuán-Vallejo J; Vera R; Willey JZ; Zedet M; Moulin S; Cordonnier C; Klijn CJM; Kanselaar K; Dirks M; Silver B; Khan M; Azarpazhooh MR; Godoy DA; Roffe C; Paley L; Bray BD; Smith CJ; Di Napoli M;
J Stroke Cerebrovasc Dis; 2018 Jan; 27(1):246-256. PubMed ID: 28935502
[TBL] [Abstract][Full Text] [Related]
29. Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.
Tanne D; Macko RF; Lin Y; Tilley BC; Levine SR;
Stroke; 2006 Jul; 37(7):1798-804. PubMed ID: 16763191
[TBL] [Abstract][Full Text] [Related]
30. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
[TBL] [Abstract][Full Text] [Related]
31. The safety and effectiveness of low-dose recombinant tissue plasminogen activator (0.6 mg/kg) therapy for elderly acute ischemic stroke patients (≥ 80 years old) in the pre-endovascular era.
Takayanagi S; Ochi T; Hanakita S; Suzuki Y; Maeda K
Neurol Med Chir (Tokyo); 2014 Jun; 54(6):435-40. PubMed ID: 24670312
[TBL] [Abstract][Full Text] [Related]
32. Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience.
Sallustio F; Koch G; Di Legge S; Rossi C; Rizzato B; Napolitano S; Samà D; Arnò N; Giordano A; Tropepi D; Misaggi G; Diomedi M; Del Giudice C; Spinelli A; Fabiano S; Stefanini M; Konda D; Reale CA; Pampana E; Simonetti G; Stanzione P; Gandini R
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e323-31. PubMed ID: 23379980
[TBL] [Abstract][Full Text] [Related]
33. Absolute blood eosinophil count could be a potential biomarker for predicting haemorrhagic transformation after intravenous thrombolysis for acute ischaemic stroke.
Jucevičiūtė N; Mikužis P; Balnytė R
BMC Neurol; 2019 Jun; 19(1):127. PubMed ID: 31195995
[TBL] [Abstract][Full Text] [Related]
34. Symptomatic Intracerebral Hemorrhage after Intravenous Thrombolysis: Predictive Factors and Validation of Prediction Models.
Nisar T; Hanumanthu R; Khandelwal P
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104360. PubMed ID: 31501036
[TBL] [Abstract][Full Text] [Related]
35. Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients With History of Stroke Plus Diabetes Mellitus.
Ehrlich ME; Liang L; Xu H; Kosinski AS; Hernandez AF; Schwamm LH; Smith EE; Fonarow GC; Bhatt DL; Peterson ED; Xian Y
Stroke; 2019 Jun; 50(6):1497-1503. PubMed ID: 31035901
[TBL] [Abstract][Full Text] [Related]
36. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
37. Recombinant tissue plasminogen activator (rTPA) management for first onset acute ischemic stroke with covid -19 and non-covid -19 patients.
Khedr EM; Abdelwarith A; Moussa G; Saber M
J Stroke Cerebrovasc Dis; 2023 Apr; 32(4):107031. PubMed ID: 36701854
[TBL] [Abstract][Full Text] [Related]
38. Association of admission neutrophil serine proteinases levels with the outcomes of acute ischemic stroke: a prospective cohort study.
Li L; Han Z; Wang R; Fan J; Zheng Y; Huang Y; Yang Z; Yan F; Liu P; Zhao H; Ma Q; Luo Y
J Neuroinflammation; 2023 Mar; 20(1):70. PubMed ID: 36906528
[TBL] [Abstract][Full Text] [Related]
39. Renal Dysfunction Associated with Symptomatic Intracranial Hemorrhage after Intravenous Thrombolysis.
Zhu J; Shen X; Han C; Mei C; Zhou Y; Wang H; Kong Y; Jiang Y; Fang Q; Cai X
J Stroke Cerebrovasc Dis; 2019 Nov; 28(11):104363. PubMed ID: 31501038
[TBL] [Abstract][Full Text] [Related]
40. Risk Factors Associated With Exclusion of Obese Patients Ischemic Stroke With a History of Smoking From Thrombolysis Therapy.
Brewer PC; Ojo DT; Broughton PX; Imeh-Nathaniel A; Imeh-Nathaniel S; Nathaniel TI
Clin Appl Thromb Hemost; 2024; 30():10760296241246264. PubMed ID: 38600881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
